热门资讯> 正文
Acumen Pharmaceuticals申请2亿美元混合货架产品
2024-03-28 04:58
- Acumen Pharmaceuticals (NASDAQ:ABOS) Wednesday filed a prospectus related to a proposed mixed shelf offering of up to $200M.
- This prospectus is not an offer to sell these securities.
- SEC Filing
More on Acumen Pharmaceuticals
- Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript
- Acumen Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Acumen Pharmaceuticals
- Historical earnings data for Acumen Pharmaceuticals
- Financial information for Acumen Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。